Leading the Way in Stable ISsotope Applications
Cambridge Isotope Laboratories, Inc. (CIL) is the world's premier producer of stable isotope labeled compounds and the world leader in the field of isotope separations with an annual production capacity of 120 kilograms of Carbon-13 and annual production capacity of 250 kilograms of Oxygen-18. For more than 20 years, CIL has specialized in the development, production, and marketing of stable (non-radioactive) isotopes and chemical compounds labeled with stable isotopes. With an inventory of over 8000 products, CIL has the most complete product offering of stable isotope labeled compounds available.
CIL employs 130 people at its state-of-the-art 57,000 square foot Andover, Massachusetts production laboratories and its Xenia, Ohio isotope separation facility. CIL's chemists are experts in their fields, with extensive years of experience exclusively in the synthesis of stable isotope labeled compounds.
Joel Bradley, a Ph.D. organic chemist from MIT, founded Cambridge Isotope Laboratories (CIL) in 1981. From the beginning, CIL's mission has been to drive the expansion of market applications of stable isotopes with innovative product development while providing the highest quality product and unsurpassed service to our customers. Since 1981, CIL has worked with leading scientific groups in the fields of environmental ultratrace analysis, metabolic research, molecular biology, protein structure analysis, clinical and diagnostic research who have turned to the use of stable isotopes in order to solve their most demanding problems.